Huron Consulting Group

Huron Consulting Group’s stock dropped to a 52-week low, trading near the roughly $100 mark after losing about 40.6% over six months and 38.6% year-to-date. Despite the sell-off, Huron beat expectations in Q1 2026 with EPS of $1.73 and revenue of $443.7 million. Management has been executing aggressive share buybacks, the P/E ratio is 18.03, and the company acquired RelateCare to expand its healthcare services portfolio with AI-powered patient solutions. » More on de.investing.com

Huron Consulting Group shares hit a new 52-week low at $100.20 and are down about 39% year-to-date (six months: -36%). Despite the weakness, InvestingPro rates the stock as undervalued and points to upside potential and aggressive share buybacks by management. Market capitalization and valuation stand at roughly $1.52 billion and a P/E ratio of 17.63, respectively. In addition, Huron beat expectations in Q1 2026 on revenue ($443.7 million) and EPS ($1.73), and shareholders elected eight board members. » More on de.investing.com

At the annual meeting, shareholders elected eight members to Huron Consulting Group’s board of directors and approved, in an advisory vote, the compensation of the named executives. They also ratified PricewaterhouseCoopers LLP as the independent auditor for the fiscal year ending December 31, 2026. A total of 15,777,409 shares were represented; affirmative votes on the individual proposals ranged from about 12.8 to 15.3 million. Huron recently reported a strong first quarter of 2026 with EPS of $1.73 and revenue of $443.7 million, both above expectations. » More on de.investing.com